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Up-regulation of aldose reductase activity in cultured mesangial cells
overexpressing human aldose reductase gene is associated with increased TGF-beta1 and
collagen IV expression
QH Dan1, R Wong1, SN Yin1, SK Chung2, SSM Chung2 and KSL Lam1
1 Department of Medicine, Queen Mary Hospital, The University of Hong Kong, 2 Institute of Molecular Biology,
The University of Hong Kong
Introduction: Increased flux of glucose through the polyol pathway involving the enzyme aldose reductase (AR)
has been implicated in the pathogenesis of diabetic nephropathy. However, the proposed mechanisms to explain the
role of AR and its interaction with other pathogenetic pathways, such as enhanced production of advanced glycation
endproducts (AGEs),TGF-beta1and extracellular matrix including collagen IV in diabetic nephropathy remain
controversial. In the present study, we examined the effect of increased AR activity on TGF-beta1 and collagen IV
expression in mesangial cells derived from transgenic mice expressing human AR (hAR) with AGEs-BSA application.
Methods: We established a transgenic mouse model expressing hAR in kidney mesangial cells. Primary cultures of
the mesangial cells from hAR transgenic (TG) and wildtype (WT) mice were treated with 0.1mg/ml of either
AGEs-BSA or non-glycated BSA for 24 hours with and without the addition of an AR inhibitor, zopolrestat
(0.01mM). hAR mRNA and protein expression were measured by RT-PCR and Western blotting respectively. AR
activity, and mRNA levels of TGF-beta1 and collagen IV in mesangial cells were examined by spectrophotometry
and RT-PCR.
Results: hAR mRNA and protein expression were demonstrated in TG, but not in WT mesangial cells. AR activity
was also increased in TG mesangial cells (P<0.05 versus WT mesangial cells). Enhanced AR activity was seen in
both WT and TG mesangial cells (P<0.05), when treated with AGEs-BSA. The increase in AR activity in the
presence of AGEs-BSA was accompanied by increases in TGF-beta1 and collage IV transcripts in mesangial cells,
which reached statistical significance only in the cells from TG animals (p<0.01). Preliminary data show that this
increased TGF-beta1 mRNA expression and AR activity can be partily abolished by the addition of an AR inhibitor.
Conclusion: These results suggest that AR may be involved in the increased expression of TGF-beta1 which
contributes to the mesangial cell proliferation and matrix protein production observed in diabetic nephropathy, in
part through an interaction with AGEs.
Acknowledgement: This is an on-going project sponsored by the UDM Research Grant 02/04.
Effect of the microsomal triglyceride transfer protein -493 G/T polymorphism
and type 2 diabetes mellitus on LDL subfractions
SPL Chen, KCB Tan, KSL Lam. Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong
Introduction. Genetic variation in the microsomal triglyceride transfer protein (MTP) affects the secretion pattern
and plasma concentration of apolipoprotein (aopB)-containing lipoproteins and the common functional –493 G/T
polymorphism has been reported to influence plasma lipids levels. Recent data suggest that carriers of the T allele
might be more sensitive to detrimental factor such as features of the insulin resistance syndrome. Since type 2
diabetes is associated with obesity and insulin resistance, the present study investigated the effect of this polymor-
phism on plasma lipids, apoB and LDL subfractions in 281 Chinese type 2 diabetic patients and 364 non-diabetic
controls.
Methods. The polymorphism for each subject was determined by polymerase chain reaction, restriction enzymatic
action and subsequent electrophoresis on 3% metaphor agarose gel.
Results. The frequency of the rare T allele was 0.162 and 0.126 in subjects with and without diabetes respectively.
Diabetic subjects had significant higher body mass index and waist hip ratio than the controls (p<0.01). There were
no differences in the effect of the polymorphism on plasma lipids and apoB in the 2 groups. However, the TT
genotype was associated with a higher concentration of small dense LDL-III than the GT or GG variants in the
diabetic subjects (p = 0.01) whereas no such effect was observed in the controls. In the diabetic patients, age,
plasma triglyceride and the MTP genotype were independent determinants of LDL-III concentrations in linear
regression analysis (R2 = 10%, p <0.05) whereas in the controls, only plasma triglyceride and age were important
determinants (R2 = 15%, p <0.01).
Conclusion. The -493 G/T polymorphism has a minor effect on LDL subfraction pattern in Chinese and the effect
is only apparent in the presence of type 2 diabetes.
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